← Back to Clinical Trials
Recruiting NCT07446374

NCT07446374 Rhode Island Community-based Maternal Support Services

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07446374
Status Recruiting
Phase
Sponsor Women and Infants Hospital of Rhode Island
Condition Perinatal Outcomes
Study Type INTERVENTIONAL
Enrollment 3,000 participants
Start Date 2025-05-19
Primary Completion 2028-12

Eligibility & Interventions

Sex Female only
Min Age N/A
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Perinatal health screeningSupport services

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 3,000 participants in total. It began in 2025-05-19 with a primary completion date of 2028-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this project is to improve perinatal health outcomes in Rhode Island by bringing together the hospital, community health workers (CHWs), doulas, and community-based organizations to build a service delivery model that addresses care coordination and social determinants of health (SDOH) as a part of a concerted effort towards achieving equitable perinatal health outcomes. Over 4 years, the hospital-led project team will implement the community-based maternal support services (COMSS) bundle in 6 affiliated clinics, including care coordination, doula care, and referrals and linkages to community-based organizations that address key SDOH (food, housing, transportation). Maternal and infant health outcomes will be compared pre and post program implementation. The central hypothesis is that COMSS will reduce adverse maternal and infant outcomes and associated racial disparities.

Eligibility Criteria

Inclusion Criteria: * All birthing people receiving perinatal care (prenatal, postpartum) at Women and Infants Hospital (WIH) and its affiliated clinics Exclusion Criteria: * Anyone not meeting the above criteria

Frequently Asked Questions

Who can join the NCT07446374 clinical trial?

This trial is open to female participants only, studying Perinatal Outcomes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07446374 currently recruiting?

Yes, NCT07446374 is actively recruiting participants. Visit ClinicalTrials.gov or contact Women and Infants Hospital of Rhode Island to inquire about joining.

Where is the NCT07446374 trial being conducted?

This trial is being conducted at Pawtucket, United States, Providence, United States, Providence, United States, Providence, United States and 3 additional locations.

Who is sponsoring the NCT07446374 clinical trial?

NCT07446374 is sponsored by Women and Infants Hospital of Rhode Island. The trial plans to enroll 3,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology